"
Team:Westminster/Project
From 2012.igem.org
| Line 110: | Line 110: | ||
padding: 15px 20px; | padding: 15px 20px; | ||
border-radius: 10px; | border-radius: 10px; | ||
| + | } | ||
| + | div.three-columns { | ||
| + | padding-left: 20px; | ||
} | } | ||
div.column, img.column { | div.column, img.column { | ||
float: left; | float: left; | ||
width: 235px; | width: 235px; | ||
| - | + | margin: 10px 0px 50px 20px; | |
| - | margin: 10px 20px | + | |
border-radius: 10px; | border-radius: 10px; | ||
} | } | ||
Revision as of 19:48, 25 September 2012
Lorem Ipsum
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
